| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 775,872,842 | 715,112,301 | 8.496 | 790,909,047 | -1.901 |
| Gross Profit (Loss) | 384,226,035 | 326,588,983 | 17.648 | 385,259,335 | -0.268 |
| Operational Profit (Loss) | 194,128,148 | 203,614,307 | -4.658 | 192,085,715 | 1.063 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 192,062,164 | 174,924,439 | 9.797 | 173,138,809 | 10.929 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 226,525,778 | 174,796,305 | 29.594 | 172,515,689 | 31.307 |
| All figures are in (Actual) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 1,566,781,889 | 1,548,840,471 | 1.158 |
| Gross Profit (Loss) | 769,485,370 | 699,186,986 | 10.054 |
| Operational Profit (Loss) | 386,213,863 | 392,915,422 | -1.705 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 365,200,973 | 346,795,535 | 5.307 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 399,041,467 | 351,519,431 | 13.519 |
| Total Shareholders Equity (after Deducting Minority Equity) | 3,081,032,149 | 2,635,325,509 | 16.912 |
| Profit (Loss) per Share | 4.57 | 4.33 | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | Sales increase in general due to: |
Increase in Sales in Pharmaceuticals segment.
While noting that there is decrease in Sales in Steel industries segment.
1. Increase in Gross Profit in all segments.
2. Increase in Other income, net in others segment.
3. Decrease in Finance costs in all segments.
While noting that during similar period last year, there were lower General and administrative expenses in Steel industries segment due to reversal of excess accrual.
Decrease in Sales in Steel industries segment.
1. Increase in Other income, net in Others segment.
2. Decrease in Expense for impairment of financial assets mainly in Steel industries segment.
Increase in Sales in Pharmaceuticals segment.
1. Increase in Gross Profit in all segments.
2. Decrease in Finance costs in all segments.
While noting that during similar period last year, there were lower General and administrative expenses in Steel industries segment due to reversal of excess accrual.
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.